331 related articles for article (PubMed ID: 986921)
1. [Combined treatment of Parkinsonism with L-dopa and peripheral dopa decarboxylase inhibitors--clinical course of 13 cases and levels of serum/dopa and dopamine].
Mizuno Y; Yoshida M; Obayashi T; Ueki A
Rinsho Shinkeigaku; 1976 Jul; 16(7):511-9. PubMed ID: 986921
[No Abstract] [Full Text] [Related]
2. [The combined treatment of Parkinson's disease with L-dopa plus decarboxylase inhibitors (carbidopa, benserazide) (author's transl)].
Podiwinsky F; Mentasti M; Riederer P; Birkmayer W
Wien Klin Wochenschr; 1979 May; 91(10):332-7. PubMed ID: 452602
[TBL] [Abstract][Full Text] [Related]
3. [Effects and side effects to levodopa in parkinsonism- results of a collaborative study. (5) Combined therapy with a peripheral decarboxylase inhibitor].
Omoto T
Rinsho Shinkeigaku; 1976 Dec; 16(12):879-80. PubMed ID: 1035531
[No Abstract] [Full Text] [Related]
4. L-dopa-carbidopa: combined therapy for the treatment of Parkinson's disease.
Celesia GG; Wanamaker WM
Dis Nerv Syst; 1976 Mar; 37(3):123-5. PubMed ID: 1253661
[TBL] [Abstract][Full Text] [Related]
5. L-dopa plus dopa-decarboxylase inhibitor. Sleep organization in Parkinson's syndrome before and after treatment.
Bergonzi P; Chiurulla C; Gambi D; Mennuni G; Pinto F
Acta Neurol Belg; 1975; 75(1):5-10. PubMed ID: 1202895
[TBL] [Abstract][Full Text] [Related]
6. [Comparative studies of L-DOPA alone and combination with a peripheral DOPA decarboxylase inhibitor, HCL-benserazide, on Parkinson's disease-part I: clinical aspects (author's transl)].
Yokochi M; Kondo T; Hirayama K; Narabayashi H; Kuruma I
No To Shinkei; 1979 Mar; 31(3):295-304. PubMed ID: 444336
[No Abstract] [Full Text] [Related]
7. [Development of studies on the treatment of parkinsonian syndromes with levodopa. II. Long-term effects of L-DOPA alone or in combination with a decarboxylase inhibitor].
Rabadeau Dumas JL; Rondot P; Cardon P
Therapie; 1977; 32(2):161-72. PubMed ID: 898124
[No Abstract] [Full Text] [Related]
8. [Decarboxylase inhibitors combined with L-dopa in the treatment of Parkinson's disease].
Rondot P
Rev Prat; 1974 Mar; 24(15):1211-2, 1215-6, 1219. PubMed ID: 4416964
[No Abstract] [Full Text] [Related]
9. [L-DOPA-and dopa-decarboxylase inhibitor combination for the treatment of Parkinsonism].
Fujimori N; Kito S; Yamamoto M; Itoga E; Kosaka K
Nihon Rinsho; 1974 Mar; 32(3):579-86. PubMed ID: 4859014
[No Abstract] [Full Text] [Related]
10. Response to Sinemet 25/100 in Parkinson's disease.
Ulm G; Gerdes U; Lehmann K
Adv Neurol; 1984; 40():541-7. PubMed ID: 6695634
[No Abstract] [Full Text] [Related]
11. Report on 45-month treatment of parkinsonism with L-dopa, alone and in association with a decarboxilase inhibitor (Ro 4-4602).
Chouza C; Romero S; Gomensoro JB
Acta Neurol Latinoam; 1974; 20(1-4):116-38. PubMed ID: 4619960
[No Abstract] [Full Text] [Related]
12. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
[TBL] [Abstract][Full Text] [Related]
13. [CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].
Meco G; Casacchia M; Zamponi A; Agnoli A
Acta Neurol (Napoli); 1976; 31(4):479-48. PubMed ID: 1037427
[No Abstract] [Full Text] [Related]
14. Patient benefits of l-dopa and a decarboxylase inhibitor in the treatment of Parkinson's disease in elderly patients.
Admani AK; Verma S; Cordingley GJ; Harris RI
Pharmatherapeutica; 1985; 4(2):132-40. PubMed ID: 4059292
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of parkinsonism by L-dopa and dopa-decarboxylase inhibitor in a single tablet].
Sarova-Pinhas I; Braham J
Harefuah; 1974 Sep; 87(5):208-10. PubMed ID: 4435614
[No Abstract] [Full Text] [Related]
16. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor].
Londoõ R
Neurol Neurocir Psiquiatr; 1976; 17(4):293-300. PubMed ID: 1018729
[TBL] [Abstract][Full Text] [Related]
17. A double-blind comparison of levodopa, Madopa, and Sinemet in Parkinson disease.
Diamond SG; Markham CH; Treciokas LJ
Ann Neurol; 1978 Mar; 3(3):267-72. PubMed ID: 352236
[TBL] [Abstract][Full Text] [Related]
18. Comparison of levodopa with carbidopa or benserazide in parkinsonism.
Greenacre JK; Coxon A; Petrie A; Reid JL
Lancet; 1976 Aug; 2(7982):381-4. PubMed ID: 73849
[TBL] [Abstract][Full Text] [Related]
19. Induction of aromatic-L-amino acid decarboxylase by decarboxylase inhibitors in idiopathic parkinsonism.
Boomsma F; Meerwaldt JD; Man in 't Veld AJ; Hovestadt A; Schalekamp MA
Ann Neurol; 1989 Jun; 25(6):624-8. PubMed ID: 2742363
[TBL] [Abstract][Full Text] [Related]
20. [Decarboxylase inhibitor given in combination with l-dopa. A new therapeutic principal in parkinsonism].
Dietrichson P
Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2113-5. PubMed ID: 4590070
[No Abstract] [Full Text] [Related]
[Next] [New Search]
